SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-028175
Filing Date
2019-05-24
Accepted
2019-05-24 16:13:28
Documents
11
Period of Report
2019-07-12
Effectiveness Date
2019-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv522360_def14a.htm DEF 14A 311991
2 GRAPHIC globe.jpg GRAPHIC 3428
3 GRAPHIC proxycard_001.jpg GRAPHIC 247318
4 GRAPHIC proxycard_002.jpg GRAPHIC 286401
5 GRAPHIC tv522360_img01.jpg GRAPHIC 8346
6 GRAPHIC tv522360_img02.jpg GRAPHIC 2101
7 GRAPHIC tv522360_img03.jpg GRAPHIC 2657
8 GRAPHIC tv522360_img05.jpg GRAPHIC 877
9 GRAPHIC tv522360_img06.jpg GRAPHIC 924
10 GRAPHIC tv522360_img07.jpg GRAPHIC 2119
11 GRAPHIC tv522360_img08.jpg GRAPHIC 2601
  Complete submission text file 0001144204-19-028175.txt   1081367
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 19854583
SIC: 2834 Pharmaceutical Preparations